JP2005519035A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519035A5 JP2005519035A5 JP2003548857A JP2003548857A JP2005519035A5 JP 2005519035 A5 JP2005519035 A5 JP 2005519035A5 JP 2003548857 A JP2003548857 A JP 2003548857A JP 2003548857 A JP2003548857 A JP 2003548857A JP 2005519035 A5 JP2005519035 A5 JP 2005519035A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- mouse
- spots
- peptide
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT19242001 | 2001-12-07 | ||
| PCT/EP2002/013791 WO2003047602A1 (en) | 2001-12-07 | 2002-12-05 | Immunostimulatory oligodeoxynucleotides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519035A JP2005519035A (ja) | 2005-06-30 |
| JP2005519035A5 true JP2005519035A5 (https=) | 2006-01-26 |
Family
ID=3689335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003548857A Withdrawn JP2005519035A (ja) | 2001-12-07 | 2002-12-05 | 免疫促進性オリゴデオキシヌクレオチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050250716A1 (https=) |
| EP (1) | EP1450821A1 (https=) |
| JP (1) | JP2005519035A (https=) |
| AU (1) | AU2002358616A1 (https=) |
| CA (1) | CA2452909A1 (https=) |
| WO (1) | WO2003047602A1 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ517929A (en) * | 1999-09-25 | 2004-02-27 | Univ Iowa Res Found | Immunostimulatory nucleic acids |
| WO2002094845A2 (en) | 2001-05-21 | 2002-11-28 | Intercell Ag | Method for stabilising of nucleic acids |
| WO2004011650A2 (en) | 2002-07-24 | 2004-02-05 | Intercell Ag | Antigens encoded by alternative reading frame from pathogenic viruses |
| WO2004024182A2 (en) | 2002-09-13 | 2004-03-25 | Intercell Ag | Method for isolating hepatitis c virus peptides |
| EP1608402B1 (en) * | 2003-03-24 | 2010-10-20 | Intercell AG | Improved vaccines |
| EP2311988A1 (en) | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae antigens |
| JP4734241B2 (ja) * | 2003-07-11 | 2011-07-27 | インターツェル・アクチェンゲゼルシャフト | Ｈｃｖワクチン |
| CN1867355A (zh) * | 2003-08-11 | 2006-11-22 | 财团法人阪大微生物病研究会 | 包含诱导粘膜免疫的佐剂的新型疫苗 |
| JP4817599B2 (ja) * | 2003-12-25 | 2011-11-16 | 独立行政法人科学技術振興機構 | 免疫活性増強剤とこれを用いた免疫活性の増強方法 |
| US20060025368A1 (en) * | 2004-07-23 | 2006-02-02 | Advisys, Inc. | Growth hormone releasing hormone enhances vaccination response |
| JP4538522B2 (ja) | 2005-11-25 | 2010-09-08 | コーリー ファーマシューティカル ゲーエムベーハー | 免疫刺激性オリゴリボヌクレオチド |
| EP2292644A3 (en) | 2006-07-07 | 2011-05-25 | Intercell AG | Small Streptococcus pyogenes antigens and their use |
| JP2010503384A (ja) | 2006-09-15 | 2010-02-04 | インターセル アーゲー | ボレリア（Ｂｏｒｒｅｌｉａ）抗原 |
| EP1923069A1 (en) | 2006-11-20 | 2008-05-21 | Intercell AG | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| CA2675379A1 (en) | 2007-01-12 | 2008-07-17 | Intercell Ag | Protective proteins of s. agalactiae, combinations thereof and methods of using the same |
| CN102015754A (zh) | 2007-05-02 | 2011-04-13 | 英特塞尔股份公司 | 克雷伯菌（Klebsiella）抗原 |
| CN101883782A (zh) | 2007-06-18 | 2010-11-10 | 英特塞尔股份公司 | 衣原体抗原 |
| AU2009226949A1 (en) | 2008-03-17 | 2009-09-24 | Intercell Ag | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| ES2569907T3 (es) | 2008-06-27 | 2016-05-13 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
| US20130243779A1 (en) | 2009-02-05 | 2013-09-19 | Intercell Ag | Peptides protective against e. faecalis, methods and uses relating thereto |
| EP2405938A2 (en) | 2009-02-13 | 2012-01-18 | Intercell AG | Nontypable haemophilus influenzae antigens |
| US8454547B2 (en) * | 2009-02-25 | 2013-06-04 | The Invention Science Fund I, Llc | Device, system, and method for controllably reducing inflammatory mediators in a subject |
| WO2011031139A1 (en) | 2009-09-09 | 2011-03-17 | Universiteit Utrecht Holding B.V. | An ataq protein or a part thereof as a vaccine |
| SA110310855B1 (ar) | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
| PL2753352T5 (pl) | 2010-09-03 | 2022-10-17 | Valneva Austria Gmbh | Izolowany polipeptyd białek toksyny a i toksyny b z c. difficile i jego zastosowania |
| SG190222A1 (en) | 2010-11-10 | 2013-06-28 | Leti Sl Lab | New adjuvant |
| DE102011018499A1 (de) | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut |
| WO2014107663A2 (en) * | 2013-01-07 | 2014-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating cutaneous t cell lymphoma |
| UA130246C2 (uk) | 2013-09-19 | 2025-12-31 | Зоетіс Сервісіз Ллс | Ад'ювант на основі олії |
| CN115317600A (zh) | 2015-01-16 | 2022-11-11 | 硕腾服务有限责任公司 | 口蹄疫疫苗 |
| US20180256633A1 (en) | 2015-09-18 | 2018-09-13 | Rijksuniversiteit Groningen | Long chain inulin for stimulating an immune response |
| EP3972639A1 (en) | 2019-05-20 | 2022-03-30 | Valneva SE | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3725545A (en) * | 1971-02-03 | 1973-04-03 | R Maes | Enhancement of antibody production by nucleic acid-polycation complexes |
| US3906092A (en) * | 1971-11-26 | 1975-09-16 | Merck & Co Inc | Stimulation of antibody response |
| CA2121696C (en) * | 1991-10-23 | 2003-07-08 | James R. Lupski | Fingerprinting bacterial strains using repetitive dna sequence amplification |
| EP1167379A3 (en) * | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| FI970588A7 (fi) * | 1994-08-12 | 1997-04-11 | Wellstat Therapeutics Corp | Menetelmät verenmyrkytyksen tai tulehdussairauksien hoitamiseksi oksipuriininukleosideillä |
| RS50101B (sr) * | 1996-02-24 | 2009-01-22 | Boehringer Ingelheim International Gmbh., | Farmaceutski preparati za imunomodulaciju |
| US6589940B1 (en) * | 1997-06-06 | 2003-07-08 | Dynavax Technologies Corporation | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| DE19803453A1 (de) * | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
| ATE375169T1 (de) * | 2000-04-14 | 2007-10-15 | Intercell Ag | Modifizierte peptide enthaltende pharmazeutische präparationen |
| RU2413520C2 (ru) * | 2000-06-08 | 2011-03-10 | Интерселл Аг | Вакцинная композиция, содержащая иммуностимулирующие олигодезоксинуклеотиды |
| AT410173B (de) * | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| US7244438B2 (en) * | 2001-01-05 | 2007-07-17 | Intercell Ag | Uses for polycationic compounds |
| WO2002094845A2 (en) * | 2001-05-21 | 2002-11-28 | Intercell Ag | Method for stabilising of nucleic acids |
| US7276489B2 (en) * | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| CA2388049A1 (en) * | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Immunostimulatory oligonucleotides and uses thereof |
| EP1608402B1 (en) * | 2003-03-24 | 2010-10-20 | Intercell AG | Improved vaccines |
| CN1764473A (zh) * | 2003-03-24 | 2006-04-26 | 英特塞尔股份公司 | 矾与Th1免疫应答诱导佐剂用于增强免疫应答的用途 |
-
2002
- 2002-12-05 AU AU2002358616A patent/AU2002358616A1/en not_active Abandoned
- 2002-12-05 WO PCT/EP2002/013791 patent/WO2003047602A1/en not_active Ceased
- 2002-12-05 JP JP2003548857A patent/JP2005519035A/ja not_active Withdrawn
- 2002-12-05 EP EP02792903A patent/EP1450821A1/en not_active Ceased
- 2002-12-05 US US10/497,591 patent/US20050250716A1/en not_active Abandoned
- 2002-12-05 CA CA002452909A patent/CA2452909A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519035A5 (https=) | ||
| JP2003535146A5 (https=) | ||
| US6140482A (en) | Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same | |
| US7115579B2 (en) | Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides | |
| EP1390495B1 (en) | Immunostimulatory oligodeoxynucleic molecules | |
| DE60100814T2 (de) | Immunstimulierende oligodeoxynukleotide | |
| US5672697A (en) | Nucleoside 5'-methylene phosphonates | |
| US7709449B2 (en) | Nucleic acid-based compounds and methods of use thereof | |
| ES2543207T3 (es) | Métodos y composiciones para la inhibición de respuestas inmunes innatas y autoinmunidad | |
| EP1286695B1 (en) | Antigenic composition comprising a polycationic peptide and inosine and cytosine | |
| EP2361980B1 (en) | Methods and compositions for inhibition of immune responses and autoimmunity | |
| US7105495B2 (en) | Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides | |
| JP2010148524A (ja) | ５’ｃｐｇ核酸およびその使用方法 | |
| JP2006515277A5 (https=) | ||
| JP2003144184A (ja) | 免疫調節オリゴヌクレオチド | |
| JP2002531053A5 (https=) | ||
| Kozlov et al. | Nonenzymatic oligomerization reactions on templates containing inosinic acid or diaminopurine nucleotide residues | |
| US6531589B1 (en) | Base protecting groups and synthons for oligonucleotide synthesis | |
| An et al. | Synthesis of novel 3′-methylene H-phosphonate thymidines | |
| Sun | Utilization of modified nucleotides to probe DNA structure and function | |
| JPH07258095A (ja) | 新規抗ｈｉｖ剤 | |
| JPH07258096A (ja) | 新規抗ｈｉｖ剤 | |
| HK1164361B (en) | Methods and compositions for inhibition of immune responses and autoimmunity |